HPV疫苗是安全的,如果在16岁之前接种,则将宫颈癌风险降低80%,没有严重的副作用。 HPV vaccine is safe and cuts cervical cancer risk by 80% when given before age 16, with no serious side effects.

两次新的全球数据Cochrane审查证实,HPV疫苗是安全的,如果在16岁之前接种,将宫颈癌风险降低80%,与不孕症或慢性疲劳等严重副作用无关。 Two new Cochrane reviews of global data confirm the HPV vaccine is safe and reduces cervical cancer risk by 80% when given before age 16, with no link to serious side effects like infertility or chronic fatigue. 调查结果以46个国家的1.32亿多人为基础,显示对先发性损伤和生殖器元体的有力保护,澳大利亚和苏格兰的实际结果显示,在接种疫苗的年轻妇女中,没有新的子宫颈癌病例。 The findings, based on over 132 million people across 46 countries, show strong protection against precancerous lesions and genital warts, with real-world results from Australia and Scotland showing no new cervical cancer cases among vaccinated young women. 针对九种致癌的HPV菌株的疫苗被推荐给9至26岁的儿童,在45岁之前有补习选择,并且仍然是在美国预防每年近48 000例与HPV有关的癌症的一个重要工具。 The vaccine, which targets nine cancer-causing HPV strains, is recommended for children ages 9 to 26, with catch-up options to age 45, and remains a key tool in preventing nearly 48,000 annual HPV-related cancers in the U.S.